Sandimmun Neoral: Taiwanese experience in renal transplant patients with special reference to patients with existing liver disease

PO-HUANG LEEREY-HENG HUKEH-SUNG TSAIChern H.-D.Gau Y.-S.Chen R.R.-L.2020-11-192020-11-1919960041-1345https://www.scopus.com/inward/record.uri?eid=2-s2.0-0029889865&partnerID=40&md5=a4edfc7542432deed59258b7484cc38dhttps://scholars.lib.ntu.edu.tw/handle/123456789/521617[SDGs]SDG3cyclosporin a; area under the curve; conference paper; drug absorption; drug bioavailability; drug formulation; drug safety; drug tolerability; hepatitis b; hepatitis c; human; kidney allograft; kidney transplantation; liver function; mean residence time; oral drug administration; priority journal; steady state; Administration, Oral; Cyclosporine; Dosage Forms; Humans; Immunosuppressive Agents; Kidney Transplantation; Liver Diseases; Metabolic Clearance Rate; TaiwanSandimmun Neoral: Taiwanese experience in renal transplant patients with special reference to patients with existing liver diseaseconference paper86586792-s2.0-0029889865